JP2004532638A - p53経路のモディファイヤーとしてのMAP3Ksおよび使用方法 - Google Patents
p53経路のモディファイヤーとしてのMAP3Ksおよび使用方法 Download PDFInfo
- Publication number
- JP2004532638A JP2004532638A JP2003502009A JP2003502009A JP2004532638A JP 2004532638 A JP2004532638 A JP 2004532638A JP 2003502009 A JP2003502009 A JP 2003502009A JP 2003502009 A JP2003502009 A JP 2003502009A JP 2004532638 A JP2004532638 A JP 2004532638A
- Authority
- JP
- Japan
- Prior art keywords
- mapk
- assay
- modulator
- assay system
- pathway
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/527—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving lyase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57449—Specifically defined cancers of ovaries
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4739—Cyclin; Prad 1
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/82—Translation products from oncogenes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/988—Lyases (4.), e.g. aldolases, heparinase, enolases, fumarase
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/04—Screening involving studying the effect of compounds C directly on molecule A (e.g. C are potential ligands for a receptor A, or potential substrates for an enzyme A)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/10—Screening for compounds of potential therapeutic value involving cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2510/00—Detection of programmed cell death, i.e. apoptosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Pathology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Organic Chemistry (AREA)
- Food Science & Technology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29607601P | 2001-06-05 | 2001-06-05 | |
US32860501P | 2001-10-10 | 2001-10-10 | |
US35725302P | 2002-02-15 | 2002-02-15 | |
US36119602P | 2002-03-01 | 2002-03-01 | |
PCT/US2002/017457 WO2002098889A2 (fr) | 2001-06-05 | 2002-06-03 | Map3ks utiles en tant que modificateurs de la voie p53 et methodes d'utilisation |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2004532638A true JP2004532638A (ja) | 2004-10-28 |
Family
ID=27501675
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003502009A Withdrawn JP2004532638A (ja) | 2001-06-05 | 2002-06-03 | p53経路のモディファイヤーとしてのMAP3Ksおよび使用方法 |
JP2003502178A Withdrawn JP2005514906A (ja) | 2001-06-05 | 2002-06-03 | p53経路のモディファイヤーとしてのLCEsおよび使用方法 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2003502178A Withdrawn JP2005514906A (ja) | 2001-06-05 | 2002-06-03 | p53経路のモディファイヤーとしてのLCEsおよび使用方法 |
Country Status (5)
Country | Link |
---|---|
EP (2) | EP1402051A4 (fr) |
JP (2) | JP2004532638A (fr) |
AU (1) | AU2002314887A1 (fr) |
CA (2) | CA2448112A1 (fr) |
WO (4) | WO2002099068A2 (fr) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10254601A1 (de) * | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
AU2012233044B2 (en) * | 2002-11-22 | 2015-09-03 | Ganymed Pharmaceuticals Ag | Genetic products differentially expressed in tumors and the use thereof |
AU2003297318A1 (en) * | 2002-12-20 | 2004-07-22 | Millennium Pharmaceuticals, Inc. | Methods and compositions for treating cancer using 15986, 2188, 20743, 9148, 9151, 9791, 44252, 14184, 42461, 8204, 7970, 25552, 21657, 26492, 2411, 15088, 1905, 28899, 63380, 33935, 10480, 12686, 25501, 17694, 15701, 53062, 49908, 21612, 38949, 6216, 46863, 9235, 2201, 6985, 9883, 12238, 18057, 21617, 39228, 49928, 54476. |
DE10316701A1 (de) * | 2003-04-09 | 2004-11-04 | Hinzmann, Bernd, Dr. | Humane Nukleinsäuresequenzen aus Bronchialkarzinomen |
CA2532150A1 (fr) | 2003-07-11 | 2005-01-20 | Banyu Pharmaceutical Co., Ltd. | Methode d'evaluation de compose efficace dans le traitement de l'obesite |
EP1677739A4 (fr) * | 2003-09-04 | 2008-07-23 | Immusol Inc | Methodes permettant d'identifier des agents qui inhibent la croissance des cellules cancereuses |
WO2005083425A2 (fr) * | 2004-02-26 | 2005-09-09 | Bayer Healthcare Ag | Agents de diagnostic et de therapie destines aux maladies associees a la proteine kinase 13 activee par un mitogene (map3k13) |
JP2008502151A (ja) | 2004-06-04 | 2008-01-24 | ザ ボード オブ トラスティーズ オブ ザ ユニヴァーシティー オブ イリノイ | 印刷可能半導体素子を製造して組み立てるための方法及びデバイス |
CN105826345B (zh) | 2007-01-17 | 2018-07-31 | 伊利诺伊大学评议会 | 通过基于印刷的组装制造的光学系统 |
EP2430652B1 (fr) | 2009-05-12 | 2019-11-20 | The Board of Trustees of the University of Illionis | Ensembles imprimés de diodes électroluminescentes inorganiques microscopiques ultraminces pour dispositifs d'affichage déformables et semi-transparents |
US9442285B2 (en) | 2011-01-14 | 2016-09-13 | The Board Of Trustees Of The University Of Illinois | Optical component array having adjustable curvature |
WO2012158709A1 (fr) | 2011-05-16 | 2012-11-22 | The Board Of Trustees Of The University Of Illinois | Barrettes de del à gestion thermique assemblées par impression |
EP2713863B1 (fr) | 2011-06-03 | 2020-01-15 | The Board of Trustees of the University of Illionis | Réseau d'électrodes de surface conformables, multiplexées de manière active et à haute densité, pour un interfaçage avec le cerveau |
US9691873B2 (en) | 2011-12-01 | 2017-06-27 | The Board Of Trustees Of The University Of Illinois | Transient devices designed to undergo programmable transformations |
CN114181944B (zh) * | 2020-09-14 | 2023-10-03 | 中国科学院动物研究所 | 突变基因及构建短肢性侏儒症小型猪模型的方法和用途 |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK0572478T3 (da) * | 1991-02-22 | 2006-01-16 | Inst Medical W & E Hall | HBGAD- og HIGAD-polypeptider og nukleinsyre og anvendelse heraf til diagnostik og behandling af GAD-autoantigen-associerede sygdomme |
US5405941A (en) * | 1993-04-15 | 1995-04-11 | National Jewish Center For Immunology And Respiratory Medicine | MEKK protein, capable of phosphorylating MEK |
US5554523A (en) * | 1994-03-01 | 1996-09-10 | Children's Hospital Of Philadelphia | Nucleic acid sequences encoding human leucine-zipper protein-kinase |
AU3289599A (en) * | 1998-02-13 | 1999-08-30 | Cadus Pharmaceutical Corporation | Mekk1 proteins and fragments thereof for use in regulating apoptosis |
AU3354499A (en) * | 1998-03-16 | 1999-10-11 | Cadus Pharmaceutical Corporation | Human mekk proteins, corresponding nucleic acid molecules, and uses therefor |
WO2000055330A1 (fr) * | 1999-03-18 | 2000-09-21 | The University Of Bristol | Elongase d'acides gras polyinsatures tires de caenorhabiditis elegans |
CA2370195A1 (fr) * | 1999-04-23 | 2000-11-02 | Incyte Genomics, Inc. | Proteines humaines associees aux membranes |
WO2001007586A2 (fr) * | 1999-07-22 | 2001-02-01 | The University Of British Columbia | Enzyme biosynthetique d'acides gras a chaines longues de plantes |
JP2003520032A (ja) * | 1999-11-12 | 2003-07-02 | ヒューマン ジノーム サイエンシーズ, インコーポレイテッド | 24個のヒト分泌タンパク質 |
US6436703B1 (en) * | 2000-03-31 | 2002-08-20 | Hyseq, Inc. | Nucleic acids and polypeptides |
AU2001270045A1 (en) * | 2000-06-20 | 2002-01-02 | Incyte Genomics, Inc. | Secreted proteins |
AU2001291745B2 (en) * | 2000-08-11 | 2007-03-29 | Merck Patent Gmbh | Novel mitogen activated kinase |
EP1341920A2 (fr) * | 2000-11-29 | 2003-09-10 | Xenon Genetics, Inc. | Genes humains de l'elongase et leurs utilisations |
JP2005504503A (ja) * | 2001-02-06 | 2005-02-17 | インサイト・ゲノミックス・インコーポレイテッド | 受容体および膜関連タンパク質 |
WO2002062974A2 (fr) * | 2001-02-08 | 2002-08-15 | Bayer Aktiengesellschaft | Regulation de la proteine humaine elongase hselo1 |
WO2002062975A2 (fr) * | 2001-02-08 | 2002-08-15 | Bayer Aktiengesellschaft | Regulation de la proteine humaine du type elongase hselo1 |
WO2002096943A1 (fr) * | 2001-05-25 | 2002-12-05 | Asahi Kasei Kabushiki Kaisha | Genes activant le stat6 |
AU2003231531A1 (en) * | 2002-04-24 | 2003-11-10 | Incyte Corporation | Kinases and phosphatases |
-
2002
- 2002-06-03 JP JP2003502009A patent/JP2004532638A/ja not_active Withdrawn
- 2002-06-03 WO PCT/US2002/017739 patent/WO2002099068A2/fr not_active Application Discontinuation
- 2002-06-03 AU AU2002314887A patent/AU2002314887A1/en not_active Abandoned
- 2002-06-03 WO PCT/US2002/017457 patent/WO2002098889A2/fr not_active Application Discontinuation
- 2002-06-03 WO PCT/US2002/017465 patent/WO2002098891A2/fr not_active Application Discontinuation
- 2002-06-03 WO PCT/US2002/017460 patent/WO2002098468A1/fr not_active Application Discontinuation
- 2002-06-03 CA CA002448112A patent/CA2448112A1/fr not_active Abandoned
- 2002-06-03 EP EP02732039A patent/EP1402051A4/fr not_active Withdrawn
- 2002-06-03 JP JP2003502178A patent/JP2005514906A/ja not_active Withdrawn
- 2002-06-03 EP EP02741809A patent/EP1402262A4/fr not_active Withdrawn
- 2002-06-03 CA CA002449479A patent/CA2449479A1/fr not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2002098891A3 (fr) | 2003-05-30 |
WO2002098889A2 (fr) | 2002-12-12 |
EP1402262A4 (fr) | 2005-05-11 |
CA2448112A1 (fr) | 2002-12-12 |
CA2449479A1 (fr) | 2002-12-12 |
AU2002314887A1 (en) | 2002-12-16 |
WO2002099068A3 (fr) | 2003-12-04 |
EP1402051A4 (fr) | 2005-08-17 |
EP1402262A2 (fr) | 2004-03-31 |
WO2002099068A2 (fr) | 2002-12-12 |
WO2002098891A2 (fr) | 2002-12-12 |
EP1402051A2 (fr) | 2004-03-31 |
JP2005514906A (ja) | 2005-05-26 |
WO2002098889A3 (fr) | 2003-03-27 |
WO2002098468A1 (fr) | 2002-12-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8153384B2 (en) | Marks as modifiers of the p53 pathway and methods of use | |
US20050112568A1 (en) | Dgks as modifiers of the p53 pathwha and methods of use | |
JP2004537321A (ja) | p53経路のモディファイヤーとしてのHPRP4sおよび使用方法 | |
JP2004532638A (ja) | p53経路のモディファイヤーとしてのMAP3Ksおよび使用方法 | |
JP2004534955A (ja) | p21経路のモディファイヤーとしてのHADHsおよび使用方法 | |
JP2004528045A (ja) | p53経路のモディファイヤーとしてのP5CRsおよび使用方法 | |
US8268548B2 (en) | MAP3Ks as modifiers of the p53 pathway and methods of use | |
AU2002314883A1 (en) | MAP3Ks as modifier of the p53 pathway and methods of use | |
AU2002312271A1 (en) | MARKs as modifiers of the p53 pathway and methods of use | |
AU2002312284A1 (en) | DGKS as modifiers of the p53 pathway and methods of use | |
AU2002312253A1 (en) | LIMKs as modifiers of the p53 pathway and methods of use | |
AU2002310283A1 (en) | PIBs as modifiers of the p53 pathway and methods of use | |
JP2007525964A (ja) | p53経路のモディファイヤーとしてのSPPLsおよび使用方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20050526 |
|
A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20070920 |